Cellectis Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Cellectis S.A. (CLLS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-36.76-101.06-106.14-114.20-97.48-115.21
Depreciation & Amortization19.8518.4517.9413.859.826.88
Deferred Income Tax-0.540.370.090.000.000.00
Stock Based Compensation3.175.236.0411.4910.030.00
Change in Working Capital53.6748.86-5.72-12.3021.83-11.65
Change in Accounts Receivable52.602.25-3.19-13.09-2.540.00
Change in Inventory0.000.000.000.220.100.00
Change in Accounts Payable2.06-6.313.250.185.690.00
Change in Other Working Capital-20.79-6.24-5.810.65-0.690.00
Other Operating Activities-20.797.3416.9313.0314.3529.06
Net Cash from Operating Activities22.99-24.75-87.44-104.56-80.26-69.14
Investing Activities
Capital Expenditures-3.84-1.07-2.43-18.5446.2612.96
Purchases of Investments-162.77-12.870.1314.862.880.00
Sales/Maturities of Investments63.810.49-0.01-0.01-0.350.00
Other Investing Activities0.00-1.56-0.4510.98-12.800.00
Net Cash from Investing Activities-102.81-15.51-2.767.28-54.34-35.87
Financing Activities
Debt Repayment-16.06-16.19-12.35-12.47-6.61-3.39
Common Stock Issued82.8269.990.0058.560.340.00
Common Stock Repurchased0.000.00-0.570.000.000.00
Other Financing Activities-1.05-0.607.75-0.3912.05-8.34
Net Cash from Financing Activities89.1182.871.1547.5327.32-3.86
Summary
Effect of Forex Changes on Cash-2.750.88-3.36-5.750.000.00
Net Change in Cash9.3043.49-92.42-55.51-107.28-108.88
Cash at Beginning of Period136.7193.22185.64241.15340.52451.50
Cash at End of Period143.25136.7193.22195.84267.69319.79
Free Cash Flow19.15-25.82-89.88-123.11-126.47-81.69
Supplemental Disclosures
Interest Paid0.850.330.330.370.030.00